Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav in open-angle glaucoma or ocular hypertension
NCT01514721Phase 4Terminated
- Sponsor
- Alcon Inc.
- Start
- Jun 2012
- Primary completion
- Nov 2013
- Countries
- 1
01
Overview
A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started Jun 2012; status: terminated.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT01514721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514721.